..Dr. Prasanth Manohar is working as a post-doctor in Dr Sebastian Leptihn’s lab in ZJE. He completed his Ph.D in Vellore Institute of Technology (VIT), Vellore, India, during which he was awarded with ‘Young scientist award’ from INNO Indigo projects, European Union and ‘CSIR-Senior Research Fellowship’ from Government of India. His research interests are bacteriophage biology, phage therapy and antibiotic resistance.
When asked why came to China for research, he mentioned that China is one of the fastest growing economy in the world withhands-on-use latest technologies, and there are substantial research funding sources available to meet the global needs that eventually supports the scientists to do innovation. Additionally, he loves Chinese people and the life in Haining has been pleasant.
During the COVID-19 outbreak, China carries out strict and effective prevention and control management. Therefore, Dr. Prasanth Manohar and his family still stay in India and waiting for new guideline. As a scientist in close area, Dr. Prasanth tells us that compared with SARS and MERS, covid-19 has lesser fatality rate but rapid transmission within the population. Being pandemic, countries with minimal health aids needs to be more cautious and such global emergency can only be controlled by public support. He stresses that ‘prevention is better than cure’.
When it comes to future plan, Dr. Prasanth precisely states that he wants to become one of the reputed scientists in the field of phage therapy and he is working towards bringing phage therapy into a reality to treat antibiotic resistant infections.
PHAGElogist 